The LAT Rheostat as a Regulator of Megakaryocyte Activation
Thrombosis and Haemostasis · 01.10.2024 · 124 (10) · 937-947
DOI: 10.1055/a-2332-6321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.10.2024. Verfasst von Alyssa J Moroi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin, United States. Hauptthemen laut MEDLINE: Megakaryocytes, Signal Transduction, Phospholipase C gamma, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH grant.
Abstract (Originalsprache)
Background
Specifically positioned negatively charged residues within the cytoplasmic domain of the adaptor protein, linker for the activation of T cells (LAT), have been shown to be important for efficient phosphorylation of tyrosine residues that function to recruit cytosolic proteins downstream of immunoreceptor tyrosine-based activation motif (ITAM) receptor signaling. LAT tyrosine 132—the binding site for PLC-γ2—is a notable exception, preceded instead by a glycine, making it a relatively poor substrate for phosphorylation. Mutating Gly131 to an acidic residue has been shown in T cells to enhance ITAM-linked receptor-mediated signaling. Whether this is generally true in other cell types is not known.
Methods
To examine whether LAT Gly131 restricts ITAM signaling in cells of the megakaryocyte lineage, we introduced an aspartic acid at this position in human induced pluripotent stem cells (iPSCs), differentiated them into megakaryocytes, and examined its functional consequences. Results iPSCs expressing G131D LAT differentiated and matured into megakaryocytes normally, but exhibited markedly enhanced reactivity to glycoprotein VI (GPVI)-agonist stimulation. The rate and extent of LAT Tyr132 and PLC-γ2 phosphorylation, and proplatelet formation on GPVI-reactive substrates, were also enhanced.
Conclusion
These data demonstrate that a glycine residue at the -1 position of LAT Tyr132 functions as a kinetic bottleneck to restrain Tyr132 phosphorylation and signaling downstream of ITAM receptor engagement in the megakaryocyte lineage. These findings may have translational applications in the burgeoning field of in vitro platelet bioengineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin, United States.
- Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
- Department of Cell Biology, Neurobiology and, Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
ORCID-Profile: Alyssa J Moroi
Förderung
- NHLBI NIH HHS
- NIH grant
Zitieren
APA
Moroi, A. J., & Newman, P. J. (2024). The LAT Rheostat as a Regulator of Megakaryocyte Activation. Thrombosis and Haemostasis, 124(10), 937-947. https://doi.org/10.1055/a-2332-6321
Vancouver
Moroi AJ, Newman PJ. The LAT Rheostat as a Regulator of Megakaryocyte Activation. Thrombosis and Haemostasis. 2024;124(10):937-947. doi:10.1055/a-2332-6321
BibTeX
@article{Moroi2024,
author = {Moroi, Alyssa J and Newman, Peter J},
title = {The LAT Rheostat as a Regulator of Megakaryocyte Activation},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {10},
pages = {937--947},
doi = {10.1055/a-2332-6321}
}
EUVIMED